1-1 of 1
Déborah Garcia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

crizanlizumab and inclacumab are equally potent inhibitors of cell adhesion in the blood of patients with sickle cell disease.

Open Access
Tina Rubic-Schneider, Tomasz W Kaminski, David Ledieu, Déborah Garcia, Jeannine Hehlen, Coline Burnet-Merlin, Benjamin Cochin de Billy, Barbara Greutmann, Anthony M. DeLise, Tomasz Brzoska, Renee Bergeron, Rikesh K. Dubey, Tirthadipa Pradhan-Sundd, Frieder Krӧner, Mélanie Verneret, Andreas Bruederle, Patrick C Hines, Xiufeng Gao, Maya Dajee, Prithu Sundd
Journal: Blood Red Cells & Iron
Blood Red Cells & Iron 100025.
https://doi.org/10.1016/j.brci.2025.100025
Published: 2025
Includes: Supplemental data